Cardiac rehabilitation

European Heart Journal

Volumn 19, Issue 7, 1998, Pages 1004-1010

  Gohlke, Helmut ^a,c   Gohlke Barwolf C ^b  

^a Rehabilitationsklinik Sinnighofen   (Germany)

^b UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^c Rehabilitationsklinik Sinnghofen   (Germany)

Author keywords

Cardiac rehabilitation; Cholesterol lowering; Cost efficiency; Diet in coronary disease; Exercise training; Smoking cessation; Stress management; Vocational rehabilitation

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

COST EFFECTIVENESS ANALYSIS; DIET THERAPY; FAT INTAKE; HEART DISEASE; HEART REHABILITATION; HUMAN; PATIENT COUNSELING; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SMOKING CESSATION; STRESS; WELLBEING;

COMBINED MODALITY THERAPY; CORONARY DISEASE; EUROPE; HUMANS; MYOCARDIAL INFARCTION; RISK FACTORS;

EID: 0032127841     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1998.1018     Document Type: Review

References (120)

1. [1] Pekkanen J, Linn S, Heiss G et al. Ten year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. N Engl J Med 1990; 322: 1700-7.
2. [2] Lichtlen P, Nikutta P, Jost S, Deckers J, Wiese B, Rafflenbeul W, and the INTACT study group. Anatomical progression of coronary artery disease in humans as seen by prospective, repeated, quantitated coronary angiography: relation to clinical events and risk factors. Circulation 1992; 86: 828-38.
3. [3] Waters D, Lesperance J, Gladstone P et al. for the CCAIT Study Group. Effects of cigarette smoking on the angiographic evolution of coronary atherosclerosis - A Canadian coronary atherosclerosis intervention substudy. Circulation 1996; 94: 614-21.
4. [4] Hasdai D, Garratt KN, Grill DE, Lerman A, Holmes DR. Effect of smoking status on the long-term outcome after successful percutaneous coronary revascularization. N Engl J Med 1997; 336: 755-61.
5. [5] Hermanson B, Omenn GS, Kronmal RA, Gersh BJ, and participants of the CASS. Beneficial six-year outcome of smoking cessation in older men and women with CAD. N Engl J Med 1988; 19: 1365-9.
6. [6] Wilhelmsson C, Elmfeldt C, Vedin JA, Tibblin G. Smoking and myocardial infarction. Lancet 1975; 1: 415-19.
7. [7] Burke AP, Farb A, Malcom GT, Liang Y-H, Smialek J, Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997; 336: 1276-82.
8. [8] Hung J, Lam JYT, Lacoste L, Letchacovski G. Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin. Circulation 1995; 92: 2432-6.
9. [9] Kottke TE, Battista RN, DeFriese GH, Brekke ML. Attributes of successful smoking cessation interventions in medical practice. A meta-analysis of 39 controlled trials. JAMA 1988; 259: 2882-9.
10. [10] Kramer R, Metner B, Metz M, Franz IW. Halbjahreskatamnese einer stationären Raucherentwöhnung - Beitrag zur Qualitätssicherung stationärer Rehabilitation. Herz/Kreislauf 1997; 29: 16-4.
11. [11] Keys A, ed. Coronary heart disease in seven countries. Circulation 1970; 41 (Suppl 1): 1-211.
12. [12] Miller GJ, Cruickshank JK, Ellis LJ et al. Fat consumption and factor VII coagulant activity in middle aged men. An association between a dietary and thrombogenic coronary risk factor. Atherosclerosis 1989; 78: 19-24.
13. [13] Kelleher CC. Plasma fibrinogen and factor VII as risk factors for cardiovascular disease. Eur J Epidemiol 1992; 8 (Suppl 1): 79-82.
14. [14] Nguen VT, Larson DE, Johnson RK, Goran MI. Fat intake and adiposity in children of lean and obese parents. Am J Clin Nutr 1996; 63: 507-13.
15. [15] Verschuren WMM, Jacobs DR, Bloemberg BPM et al. Serum total cholesterol and long-term coronary heart disease mortality in different cultures: twenty-five year follow-up of the seven countries study. JAMA 1995; 274: 131-6.
16. [16] Daviglus ML, Stamler J, Greenland P, Dyer AR, Liu K. Fish consumption and the risk of coronary heart disease. What does the evidence show? Eur Heart J 1997; 18: 1841-2.
17. [17] Daviglus ML, Stamler J, Orencia AJ et al. Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med 1997; 336: 1046-53.
18. [18] Hu FB, Stampfer MJ, Manson JE et al. Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 1997; 337: 1491-9.
19. [19] Blankenhorn DH, Johnson RL, Mack WJ, El Zein HA, Vailas LI. The influence of diet on the appearance of new lesions in human coronary arteries. JAMA 1990; 263: 1646-52.
20. [20] Quinn TG, Alderman EL, McMillan A, Haskell W for the SCRIP Investigators. Development of new coronary atherosclerotic lesions during a 4 year multifactor risk reduction programme: The Stanford Coronary Risk Intervention Project (SCRIP). JACC 1994; 24: 900-8.
21. [21] Watts GF, Jackson P, Mandelia S et al. Nutrient intake and progression of coronary artery disease. Am J Cardiol 1994; 73: 328-32.
22. [22] Watts GF, Jackson P, Burke V, Lewis B. Dietary fatty acids and progression of coronary artery disease in men. Am J Clin Nutr 1996; 64: 202-9.
23. [23] Niebauer J, Hambrecht R, Velich T et al. Predictive value of lipid profile for salutary coronary angiographic changes in patients on a low-fat diet and physical exercise program. Am J Cardiol 1996; 78: 163-7.
24. [24] Welty FK, Mittleman MA, Wilson PWF et al. Hypobetalipoproteinemia is associated with low levels of hemostatic risk factors in the Framingham offspring population. Circulation 1997; 95: 825-30.
25. [25] Pietinen P, Rimm EB, Korhonen P et al. Intake of dietary fiber and risk of coronary heart disease in a cohort of Finnish men: The Alpha-Tocopherol, Beta-Carotene Cancer prevention study. Circulation 1996; 94: 2720-7.
26. [26] Kushi LH, Folsom AR, Prineas RJ, Mink PJ, Wu Y, Bostik RM. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med 1996; 335: 1156-62.
27. [27] Burr ML, Fehily AM, Gilbert JF. Effect of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 1989; 2: 757-61.
28. [28] Singh RB, Rastogi SS, Verma R et al. Randomized controlled trial of cardioprotective diet patients with recent acute myocardial infarction. Results of one year follow up. Br Med J 1992; 304: 1015-9.
29. [29] de Lorgeril M, Renaud S, Mamelle N et al. Mediterranean alphalinolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 1994; 343: 1454-9.
30. [30] de Lorgeril M, Salen P, Martin J-L et al. Effect of a Mediterranean Type of diet on the rate of cardiovascular complications in patients with coronary artery disease: insights into the cardioprotective effect of certain nutrients. JACC 1996; 28: 1103-8.
31. [31] Kang JX, Leaf A. Antiarrhythmic effects of polyunsaturated fatty acids - recent studies. Circulation 1996; 94: 1774-80.
32. [32] Pietinen P, Ascherio A, Korhonen P. Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men: the alpha tocopherol, beta-carotene cancer prevention study. Am J Epidemiol 1997; 145: 876-87.
33. [33] Kushi LH, Lenart EB, Willet WC. Health implications of Mediterranean diets in light of contemporary knowledge. Plant foods and dairy products. Am J Clin Nutr 1995; 61 (Suppl): 1407S-1415S.
34. [34] Kohlmeier L, Simonsen N, van't Veer P et al. Adipose tissue trans fatty acids and breast cancer in the European Community multicenter study on antioxidants, myocardial infarction, and breast cancer. Cancer Epidemiol Biomarkers Prev 1997; 6: 705-10.
35. [35] Pedersen TR, for the Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival study (4 S). Lancet 1994; 344: 1383-9.
36. [36] Shepherd J, Cobbe SM, Ford I et al. for the West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with Hypercholesterolemia. N Engl J Med 1995; 333: 1301-7.
37. [37] Sacks FM, Pfeffer MA, Moye LA et al. for the Cholesterol And Recurrent Events Investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996; 335: 1001-9.
38. [38] Campeau L, Knatterud GL, Domanski M et al. for The Post Coronary Artery Bypass Graft Trial Investigators. The effect of aggressive lowering of low density lipoprotein cholesterol levels and low dose anticoagulation on obstructive changes in saphenous-vein coronary artery bypass grafts. N Engl J Med 1997; 336: 153-62.
39. [39] Cashin-Hemphill L, Mack WJ, Pogoda JM et al. Beneficial effects of colestipol-niacin on coronary atherosclerosis: a 4-year follow-up. JAMA 1990; 264: 3013-7.
40. [40] Brown G, Albers JJ, Fisher LD et al. Regression of coronary artery disease as a result of intensive lipid lowering therapy in men. New Engl J Med 1990; 323: 1289-98.
41. [41] Watts GF, Lewis B, Brunt JNH et al. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St. Thomas' Atherosclerosis Regression Study (STARS). Lancet 1992; 339: 563-69.
42. [42] Bestehorn H-P, Rensing UFE, Roskamm H et al. The effect of simvastatin on progression of coronary artery disease. The multicenter Coronary Intervention Study (CIS). Eur Heart J 1997; 18: 226-34.
43. [43] Falk E. Why do plaques rupture? Circulation 1992; 86 (6 Suppl.): III 30-42.
44. [44] Brown BG, Zhao XQ, Sacco DE, Albers JJ. Lipid-Lowering and plaque regression: new insights into prevention of plaque disruption and clinical events in coronary artery disease. Circulation 1993; 87: 1781-91.
45. [45] Kaartinen M, Penttilä A, Kovanen PT. Accumulation of activated mast cells in the shoulder region of human atheroma, the predilection site of atheromatous rupture. Circulation 1994; 90: 1669-78.
46. [46] Davies MJ. Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995. Circulation 1996; 94: 2013-20.
47. [47] Davies MJ. The composition of coronary artery plaques. N Engl J Med 1997; 336: 1312-14.
48. [48] Levine GN, Keaney JF, Vita JA. Cholesterol reduction in cardiovascular disease - clinical benefits and possible mechanisms. N Engl J Med 1995; 332: 512-21.
49. [49] Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995; 91: 2844-50.
50. [50] O'Driscoll G, Green D, Taylor RR. Simvastatin an HMG-coenzyme. A reductase Inhibitor, improves endothelial function within 1 month. Circulation 1997; 95: 1126-31.
51. [51] Gould KL, Martucci JP, Goldberg DI et al. Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease: A potential noninvasive marker of healing coronary endothelium. Circulation 1994; 89: 1530-8.
52. [52] Smith SC. Risk-reduction therapy: the challenge to change. Circulation 1996; 93: 2205-11.
53. [53] Gohlke H, Mathes P, Fleck E, Keil U, Rost R für die Deutsche Gesellschaft für Kardiologie. Empfehlungen zur umfassenden Risikoverringerung für Patienten mit Koronarer Herzerkrankung. Herz\Kreislauf 1997; 29: 252.
54. [54] Jönsson B, Johannesson M, Kjekshus J, Olsson AG, Pedersen TR, Wedel H for the 4-S-Group. Cost-effectiveness of cholesterol lowering - results from the Scandinavian Simvastatin Survival Study (4S). Eur Heart J 1996; 17: 1001-7.
55. [55] Johannesson M, Jönsson B, Kjekshus J, Olsson AG, Pedersen TR, Wedel H for the 4-S-Group. Cost-effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. N Engl J Med 1997; 336: 332-6.
56. [56] EUROASPIRE Study Group (Wood DA for the). EUROASPIRE - A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. Eur Heart J 1997; 18: 1569-82.
57. [57] Enbergs A, Liese A, Heimbach M et al. Sekundärprävention der koronaren Herzkrankheit auf dem Prüfstand -Ergebnisse der EUROASPIRE-Studie in der Region Münster. Z Kardiol 1997; 86: 284-911.
58. [58] Paffenbarger RS, Hyde RT, Wing AL, Hsieh C-C. Physical activity, all cause mortality and longevity of college alumni. N Engl J Med 1986; 314: 605-13.
59. [59] Sandvik L, Erikssen J, Thaulow E, Erikssen G, Mundal R, Rodahl K. Physical fitness as a predictor of mortality among healthy, middle-aged Norwegian men. N Engl J Med 1993; 328: 533-7.
60. [60] Lakka TA, Venäläinen JM, Rauramaa R, Salonen R, Tuomilehto J, Salonen JT. Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction in men. N Engl J Med 1994; 330: 1549-54.
61. [61] Pate R, Pratt M, Blair SN, Haskell WL, Mascera CA, Bouchard C. Physical activity and public health. A recommendation from the center of disease control and prevention and the American College of Sports Medicine. JAMA 1995; 273: 402-7.
62. [62] NIH Consensus Development Panel on Physical Activity and Cardiovascular Health. Physical activity and cardiovascular health. JAMA 1996; 276: 241-6.
63. [63] Kushi LH, Fee RM, Folsom AR, Mink PJ, Anderson KE, Sellers TA. Physical activity and mortality in postmenopausal women. JAMA 1997; 227: 1287-92.
64. [64] Gohlke H, Samek L, Betz P, Roskamm H. Exercise testing provides additional prognostic information in angiographically defined subgroups of patients with coronary heart disease. Circulation 1983; 68: 979-85.
65. [65] Gohlke H, Betz P, Roskamm H. Improved risk stratification in patients with coronary artery disease. Application of a survival function using continuous exercise and angiographic variables. Eur Heart J 1988; 9: 427-34.
66. [66] Weiner DA, Ryan TJ, McCabe CH et al. Prognostic Importance of a clinical profile and exercise test in medically treated patients with coronary artery disease. JACC 1984; 3: 772-9.
67. [67] Paffenbarger RS, Hyde RT, Wing AL, Lee I-M, Jung DL, Kampert JB. The Association of changes in physical-activity level and other life style characteristics with mortality in men. N Engl J Med 1993; 328: 538-45.
68. [68] Blair SN, Kohl HW, Barlow CE, Paffenbarger RS, Gibbons LW, Macera CA. Changes in physical fitness and all cause mortality: A prospective study of healthy and unhealthy men. JAMA 1995; 273: 1093-8.
69. [69] Gohlke H. Nutzen und Risiken der Körperlichen Aktivität bei Patienten mit koronarer Herzerkrankung. Wien Klin Wochenschr 1995; 107: 760-5.
70. [70] Fletcher GF, Balady G, Blair SN et al. Statement on exercise: benefits and recommendations for physical activity programs for all Americans - a statement for health professionals by the committee on exercise and cardiac rehabilitation of the council on clinical cardiology, American Heart Association. Circulation 1996; 94: 857-62.
71. [71] Rogers MA, Yamamoto C, Hagberg JM, Holloszy JO, Ehsani AA. The effect of 7 years of intense exercise training on patients with coronary artery disease. JACC 1987; 10: 321-6.
72. [72] Oberman A, Fletcher GF, Lee J et al. Efficacy of high intensity exercise training on left ventricular ejection fraction in men with coronary artery disease (The training level comparison study). Am J Cardiol 1995; 76: 643-7.
73. [73] Hull SS, Vanoli E, Adamson PB, Verrier RL, Foreman RD, Schwartz PJ. Exercise training confers anticipatory protection from sudden death during acute myocardial infarction. Circulation 1994; 89: 548-52.
74. [74] Camacho TC, Roberts RE, Lazarus NB, Kaplan GA, Cohen RD. Physical activity and depression: Evidence from the Alameda County study. Am J Epidemiol 1991; 134: 220-31.
75. [75] Siscovick DS, Weiss NS, Fletcher RH, Lasky T. The Incidence of primary cardiac arrest during vigorous exercise. N Engl J Med 1984; 311: 874-7.
76. [76] Coats AJS, Adamopoulos S, Radaelli A et al. Controlled trial of physical training in chronic heart failure: exercise performance, hemodynamics, ventilation and autonomic function. Circulation 1992; 85: 2119-31.
77. [77] Curfman GD. The health benefits of exercise: A critical re-appraisal. N Engl J Med 1993; 328: 574-6.
78. [78] Hambrecht R, Niebauer J, Marburger C et al. Various intensities of leisure time activity in patients with CAD: effects of cardiorespiratory fitness and progression of coronary atherosclerotic lesions. J Am Coll Cardiol 1993; 22: 440-8.
79. [79] Siscovick DS, Raghunathan TE, Rautaharju P, Psaty BM, Cobb LA, Wagner EH. Clinically silent Electrocardiographic abnormalities and risk of primary cardiac arrest among hypertensive patients. Circulation 1996; 94; 1329-33.
80. [80] Haskell WL, Alderman EL, Fair JM et al. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP). Circulation 1994; 89: 975-90.
81. [81] Ornish D, Brown SE, Scherwitz LW et al. Can lifestyle changes reverse coronary heart disease. Lancet 1990; 336: 129-33.
82. [82] Shaw LW. Effects of a prescribed supervised exercise program on mortality and cardiovascular morbidity in patients after myocardial infarction: The national exercise heart disease project. Am J Cardiol 1981; 48: 39-46.
83. [83] Fletcher GF, Balady G, Froelicher VF, Hartley LH, Haskell WL, Pollock ML. Exercise standards - a statement for health care professionals from the American Heart Association. Circulation 1995; 91: 580-615.
84. [84] Sullivan MJ, Higginbotham MB, Cobb FR. Exercise training in patients with chronic heart failure delays ventilatory anaerobic threshold and improves submaximal exercise performance. Circulation 1989; 79: 324-9.
85. [85] Hornig B, Maier V, Drexler H. Physical training improves endothelial function in patients with chronic heart failure. Circulation 1996; 93: 210-4.
86. [86] Hambrecht R, Fiehn E, Yu JT et al. Effects of endurance training on mitochondrial ultrastructure and fiber type distribution in skeletal muscle of patients with stable chronic heart failure. JACC 1997; 29: 1067-73.
87. [87] Coats AJ, Adamopoulos S, Meyer TE, Conway J, Sleight P. Effects of physical training in chronic heart failure. Lancet 1990; 335: 63-6.
88. [88] Hambrecht R, Niebauer J, Fiehn E et al. Physical Training in patients with stable chronic heart failure: effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscles. JACC 1995; 25: 1239-49.
89. [89] Schuler G, Hambrecht R. Regression and non-progression of coronary artery disease with exercise. Cardiovasc Risk 1996; 3: 176-82.
90. [90] Schuler G, Hambrecht R. Körperliches Training bei Patienten mit hochgradig eingeschränkter Pumpleistung des Herzens. Z Kardiol 1996; 85 (Suppl. 6): 253-61.
91. [91] Specchia G, De Servi S, Scirè A et al. Interaction between exercise training and ejection fraction in predicting prognosis after a first myocardial infarction. Circulation 1996; 94: 978-82.
92. [92] Adamopoulos S, Ponikowski P, Cerqueani E et al. Circadian pattern of heart rate variability in chronic heart failure patients - effects of physical training. Eur Heart J 1995; 16: 1380-6.
93. [93] Meyer K, Samek L, Schwaibold S et al. Physical response to different modes of interval exercise in patients with chronic heart failure - application to exercise training. Eur Heart J 1996; 17: 1040-7.
94. [94] O'Connor GT, Buring JE, Yusuf S et al. An overview of randomized trials of rehabilitation with exercise after myocardial infarction. Circulation 1989; 80: 234-44.
95. [95] Oldridge NB, Guyatt GHH, Fischer ME, Rimm AA. Cardiac rehabilitation after myocardial infarction. Combined experience of randomized clinical trials. JAMA 1988; 260: 945-50.
96. [96] Muller JE, Abela GS, Nesto RW, Tofler GH. Triggers, acute risk factors and vulnerable plaques: the lexicon of a new frontier. J Am Coll Cardiol 1994; 23: 809-13.
97. [97] Willich SN, Maclure M, Mittleman MA, Arntz HR, Muller JE. Sudden cardiac death: support for a role triggering in causation. Circulation 1993; 87: 1442-50.
98. [98] Mittleman MA, Maclure M, Sherwood JB et al. for the determinants of myocardial infarction onset study investigators. Triggering of acute myocardial infarction onset by episodes of anger. Circulation 1995; 92: 1720-5.
99. [99] Middlekauff HR, Nguyen AH, Negrao CE et al. Impact of acute mental stress on sympathetic nerve activity and regional blood flow in advanced heart failure - implications for 'triggering' adverse cardiac events. Circulation 1997; 96: 1835-42.
100. [100] Denollet J, Brutsaert DL. Enhancing emotional well-being by comprehensive rehabilitation in patients with coronary heart disease. Eur Heart J 1995; 16: 1070-8.
101. [101] Gohlke-Bärwolf C, Gohlke H. Further evidence for beneficial effects of comprehensive cardiac rehabilitation in men with coronary artery disease. Eur Heart J 1995; 16: 1021-2.
102. [102] Petrie KJ, Weinman J, Sharpe N, Buckley J. Role of patients' view of their illness in predicting return to work and function after myocardial infarction: longitudinal study. Br Med J 1996; 312: 1191-4.
103. [103] Trzcieniecka-Green A, Steptoe A. The effect of stress management on the quality of life of patients following acute myocardial infarction or coronary bypass surgery. Eur Heart J 1996; 17: 1663-70.
104. [104] Wallen NH, Held C, Rehnquist N, Hjemdahl P. Effects of mental and physical stress on platelet function in patients with stable angina pectoris and healthy controls. Eur Heart J 1997; 18: 807-15.
105. [105] Linden W, Stossel C, Maurice J. Psychosocial Interventions for patients with coronary artery disease - a meta-analysis. Arch Intern Med 1996; 156: 745-52.
106. [106] Lipsey MW, Wilson DB. The efficacy of psychological, educational and behavioral treatment. Am Psychology 1993; 48: 1181-209.
107. [107] Roberts AH, Kewman DG, Mercier L, Hovell M. The power of nonspecific effects in healing: implications for psychosocial and biological treatments. Clin Psychol Rev 1993; 13: 375-91.
108. [108] Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction: impact on 6 month survival. JAMA 1993; 270: 1819-25.
109. [109] Ladwig KH, Roell G, Breithardt G, Budde T, Borggrefe M. Postinfarction depression and incomplete recovery 6 months after myocardial infarction. Lancet 1993; 343: 20-3.
110. [110] Carinci F, Niccolucci A, Ciampi A et al. on behalf of the Gruppo per lo Studio della Sopravvivenza nell' Infarto Miocardico (GISSI). Role of Interactions between psychological and clinical factors in determining 6-month mortality among patients with acute myocardial infarction - application of recursive partitioning techniques to the GISSI-2 database. Eur Heart J 1997; 18: 835-45.
111. [111] Hedback B, Perk J, Wodlin P. Long-term reduction of cardiac mortality after myocardial infarction: 10-year results of a comprehensive rehabilitation programme. Eur Heart J 1993; 14: 831-5.
112. [112] Boudrez H, De Backer G, Comhaire B. Return to work after myocardial infarction: results of a longitudinal population based study. Eur Heart J 1994; 15: 32-6.
113. [113] Gohlke H, Gohlke-Bärwolf C, Schnellbacher K et al. Longterm effects of aortocoronary bypass surgery on exercise tolerance and vocational rehabilitation. In: Mathes P, Halhuber MJ, eds. Controversies in cardiac rehabilitation. Berlin, New York: Springer Verlag, 1982: 71-80.
114. [114] Gohlke H, Schnellbacher K, Steinrücken H, Samek L, Roskamm H. Postoperative exercise performance determines return to work. In: Walter PI, ed. Return to work after coronary artery bypass surgery. Berlin, New York: Springer Verlag, 1985: 102-7.
115. [115] Gohlke-Bärwolf C, Gohlke H, Samek L. et al. Exercise tolerance and working capacity after valve replacement. J Heart Valve Dis 1992; 1: 189-95.
116. [116] Oldridge N, Furlong W, Feeny D et al. Economic evaluation of cardiac rehabilitation soon after acute myocardial infarction. Am J Cardiol 1993; 72: 154-61.
117. [117] Picard MH, Dennis C, Schwartz RG et al. Cost benefit analysis of early return to work after uncomplicated acute myocardial infarction. Am J Cardiol 1989; 63: 1308-14.
118. [118] Ades PA, Huang D, Weaver SO. Cardiac rehabilitation participation predicts lower rehospitalization costs. Am Heart J 1992; 123: 916-21.
119. [119] Levin LA, Perk J, Hedback B. Cardiac rehabilitation a cost analysis. J Intern Med 1991; 230: 427-34.
120. [120] Tavazzi L et al. for the Task Force of the Working Group on Cardiac Rehabilitation of the European Society of Cardiology. Definition of cardiac rehabilitation. Eur Heart J 1992; 13 (Suppl. C): 1-45.